Established in 2013 and based in San Diego, California, U.S.A., Arcturus Therapeutics, Inc. (NASDAQ: ARCT) is a global late-stage clinical pharmaceutical company and a leading global messenger RNA (mRNA) drug and vaccines company. With proprietary technologies and expertise in (i) lipid nanoparticle-mediated drug delivery technology called LUNAR®, (ii) STARR™ mRNA technology, and (iii) mRNA drug substances and drug manufacturing, Arcturus Therapeutics is engaged in the research and development of mRNA drugs that can be effective against rare diseases such as those of the liver and respiratory tract, including vaccines for infectious diseases.